Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romina Quercia

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2016
Psychiatric Symptoms in Patients Receiving DolutegravirAnna Fettiplace, Chris Stainsby, Alan Winston, et al.
Antiviral Therapy|September 11, 2019
Prevalence of pretreatment and acquired HIV-1 mutations associated with resistance to lamivudine or rilpivirine: a systematic reviewVani Vannappagari, Leigh Ragone, Cassidy Henegar, et al.
Experimental and Therapeutic Medicine|October 23, 2020
Safety and clinical effectiveness of intravitreal administration of bevacizumab (Lumiere<sup>®</sup>) in patients with neovascular age-related macular degenerationDaniel A Benisek, Julio Manzitti, Daniel Scorsetti, et al.
AIDS (London, England)|March 17, 2021
Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysisAmy G Cutrell, Jonathan M Schapiro, Carlo F Perno, et al.
Scientific Reports|October 21, 2025
Clinical manifestations and severity of COVID-19 caused by Omicron among paediatric patients aged 0-17 years in ItalyRossana Scutari, Valeria Fox, Jennifer L Nguyen, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2016
Psychiatric Symptoms in Patients Receiving DolutegravirAnna Fettiplace, Chris Stainsby, Alan Winston, et al.
Antiviral Therapy|September 11, 2019
Prevalence of pretreatment and acquired HIV-1 mutations associated with resistance to lamivudine or rilpivirine: a systematic reviewVani Vannappagari, Leigh Ragone, Cassidy Henegar, et al.
Experimental and Therapeutic Medicine|October 23, 2020
Safety and clinical effectiveness of intravitreal administration of bevacizumab (Lumiere<sup>®</sup>) in patients with neovascular age-related macular degenerationDaniel A Benisek, Julio Manzitti, Daniel Scorsetti, et al.
AIDS (London, England)|March 17, 2021
Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysisAmy G Cutrell, Jonathan M Schapiro, Carlo F Perno, et al.
Scientific Reports|October 21, 2025
Clinical manifestations and severity of COVID-19 caused by Omicron among paediatric patients aged 0-17 years in ItalyRossana Scutari, Valeria Fox, Jennifer L Nguyen, et al.
Pageof 2